Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology

Respiratory Physiology and Neurobiology

Volumn 162, Issue 3, 2008, Pages 210-215

  Mukherjee, Tapan K ^a,b   Mukhopadhyay, Srirupa ^b   Hoidal, John R ^b  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH MOHALI   (India)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Anti RAGE therapy; AT1 cells; EsRAGE; Lung; Pulmonary pathophysiology; RAGE; sRAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BLEOMYCIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYSTIC FIBROSIS; GENE TECHNOLOGY; HUMAN; LUNG ALVEOLUS; LUNG ALVEOLUS EPITHELIUM; LUNG DISEASE; LUNG FUNCTION; LUNG INJURY; LUNG METASTASIS; LUNG PARENCHYMA; LUNG TRANSPLANTATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

HUMANS; LUNG; LUNG DISEASES; RECEPTORS, IMMUNOLOGIC;

EID: 50849094595     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2008.07.001     Document Type: Article

References (31)

1. Bartling B., Hofmann H.S., Weigle B., Silber R.E., and Simm A. Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis 26 (2005) 293-301
2. Brett J., Schmidt A.M., Yan S.D., Zou Y.S., Weidman E., Pinsky D., Nowygrod R., Neeper M., Przysiecki C., Shaw A., et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143 (1993) 1699-1712
3. Calfee C.S., Budev M.M., Matthay M.A., Church G., Brady S., Uchida T., Ishizaka A., Lara A., Ranes J.L., deCamp M.M., and Arroliga A.C. Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J. Heart Lung Transpl. 26 7 (2007) 675-680
4. Calfee, C.S., Ware, L.B., Eisner, M.D., Parsons, P.E., Thompson, T., Wickersham, N., Matthay, M.A., the NHLBI ARDS Network., 2008. Plasma receptor for advanced glycation end-products and clinical outcomes in acute lung injury. Thorax.
5. Chavakis T., Bierhaus A., Al-Fakhri N., Schneider D., Witte S., Linn T., Nagashima M., Morser J., Arnold B., Preissner K.T., and Nawroth P.P. The pattern recognition receptor (RAGE) is a counter receptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 198 (2003) 1507-1515
6. Dattilo B.M., Fritz G., Leclerc E., Kooi C.W., Heizmann C.W., and Chazin W.J. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry 46 (2007) 6957-6970
7. Demling N., Ehrhardt C., Kasper M., Laue M., Knels L., and Rieber. Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells. Cell Tissue Res. 323 (2006) 475-488
8. Donato R. Intracellular and extracellular roles of S100 proteins. Microsci. Res. Technol. 60 (2003) 540-551
9. Fehrenbach H., Kasper M., Tschernig T., et al. Receptor for advanced glycation end products (RAGE) exhibits highly differential cellular and subcellular localization in rat and human lung. Cell Mol. Biol. (Noisy-le-grand) 44 (1998) 1147-1157
10. Fehrenbach H., Weiskirchen R., Kasper M., and Gressner A.M. Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology 34 (2001) 943-952
11. Foell D., Seeliger S., Vogl T., Koch H.G., Maschek H., Harms E., Sorg C., and Roth J. Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax 58 (2003) 613-617
12. Hanford L.E., Fattman C.L., Shaefer L.M., Enghild J.J., Valnickova Z., and Oury T.D. Regulation of receptor for advanced glycation end products during bleomycin-induced lung injury. Am. J. Respir. Cell Mol. Biol. 29 (2003) S77-S81
13. Hanford L.E., Enghild J.J., Valnickova Z., Petersen S.V., Schaefer L.M., Schaefer T.M., Reinhart T.A., and Oury T.D. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J. Biol. Chem. 279 (2004) 50019-50024
14. Harashima A., Yamamoto Y., Cheng C., Tsuneyama K., Myint K.M., Takeuchi A., Yoshimura K., Li H., Watanabe T., Takasawa S., Okamoto H., Yonekura H., and Yamamoto H. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression. Biochem. J. 396 (2006) 109-115
15. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., and Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97 (1999) 889-901
16. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., and Nitecki D. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270 (1995) 25752-25761
17. Katsuoka F., Kawakami Y., Arai T., et al. Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene. Biochem. Biophys. Res. Commun. 238 (1997) 512-516
18. Li J., Qu X., and Schmidt A.M. Sp1-binding elements in the promoter of RAGE are essential for amphoterins mediated gene expression in cultured neuroblastoma cells. J. Biol. Chem. 273 (1998) 30870-30878
19. Matsuse T., Ohga E., Teramoto S., Fukayama M., Nagai R., Horiuchi S., and Ouchi Y. Immunohistochemical localization of advanced glycation end products in pulmonary fibrosis. J. Clin. Pathol. 51 (1998) 515-519
20. McElroy M.C., and Kasper M. The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. Eur. Respir. J. 24 (2004) 664-673
21. Mukherjee T.K., Mukhopadhyay S., and Hoidal J.R. The role of reactive oxygen species in TNFα dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim. Biophys. Acta 1744 (2005) 213-223
22. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., and Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267 (1992) 14998-15004
23. Park L., Raman K.G., Lee K.J., Lu Y., Ferran Jr. L.J., Chow W.S., Stern D., and Schmidt A.M. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 4 (1998) 1025-1031
24. Schenk S., Schraml P., Bendik I., and Ludwig C.U. A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancer. Lung Cancer 32 (2001) 7-12
25. Schmidt A.M., Yan S.D., Yan S.F., and Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108 (2001) 949-955
26. Schraml P., Bendik I., and Ludwig C.U. Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinoma. Cancer Res. 57 (1997) 3669-3671
27. Shirasawa M., Fujiwara N., Hirabayashi S., Ohno H., Iida J., Makita K., and Hata Y. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 9 (2004) 165-174
28. Uchida T., Shirasawa M., Ware L.B., Kojima K., Hata Y., Makita K., Mednick G., Matthay Z.A., and Matthay M.A. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am. J. Respir. Crit. Care Med. 173 (2006) 1008-1015
29. Wendt T., Tanji N., Guo J., Hudson B.I., Bierhaus A., Ramasamy R., Arnold B., Nawroth P.P., Yan S.F., D'Agati V., and Schmidt A.M. Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy. J. Am. Soc. Nephrol. 14 (2003) 1383-1395
30. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996) 685-691
31. Yonekura H., Yamamoto Y., Sakurai S., Petrova R.G., Abedin M.J., Li H., Yasui K., Takeuchi M., Makita Z., Takasawa S., Okamoto H., Watanabe T., and Yamamoto H. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem. J. 370 (2003) 1097-1109